V
52
2
ROK
47
4
A
43
-5
EXPD
51
16
DUK
52
-5
SE
49
2
NSC
48
-11
TJX
53
-9
MMM
56
2
GD
62
5
VIX
22
-14
EOG
33
-3
F
59
3
WAT
49
2
HPE
75
7
GIS
58
-2
RSG
47
2
PSA
35
-11
NDAQ
74
4
CHRW
82
3
V
52
2
ROK
47
4
A
43
-5
EXPD
51
16
DUK
52
-5
SE
49
2
NSC
48
-11
TJX
53
-9
MMM
56
2
GD
62
5
VIX
22
-14
EOG
33
-3
F
59
3
WAT
49
2
HPE
75
7
GIS
58
-2
RSG
47
2
PSA
35
-11
NDAQ
74
4
CHRW
82
3
Financhill
Back

Niagen Bioscience, Inc. 10K Form

Buy
53

NAGE
Niagen Bioscience, Inc.

Last Price:
$6.71
Seasonality Move:
21.45%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive NAGE News And Ratings

See the #1 stock for the next 7 days that we like better than NAGE

NAGE Financial Statistics

Sales & Book Value

Annual Sales: $99.6M
Cash Flow: $3.7M
Price / Cash Flow: 26.14
Annual Sales: $0.89
Price / Book: 7.37

Profitability

EPS (TTM): 0.24330
Net Income (TTM): $20.4M
Gross Margin: $61.6M
Return on Equity: 37.74%
Return on Assets: 25.81%

Niagen Bioscience, Inc. Earnings Forecast

Key Niagen Bioscience, Inc. Financial Ratios

  • The Gross Profit Margin over the past 19 years for NAGE is 61.84%.
  • The Selling, General & Administrative Expenses for NAGE have been equal to 48.04% of Gross Profit Margin.
  • The Research & Development expenses have been 6.04% of Revenue.
  • The Interest Expense is 0.00% of Operating Income.
  • The Net Earning history of NAGE is 8.58% of Total Revenues.
  • Per Share Earnings over the last 19 years have been positive in 9 years.

Niagen Bioscience, Inc. Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Life Sciences Tools & Services
Sector: Health Care
Current Symbol: NAGE
Website: niagenbioscience.com

Debt

Debt-to-Equity Ratio: 0.04
Current Ratio: 4.12
Quick Ratio: 3.21

Price-to-Earnings

Trailing P/E Ratio: 59.69
Forward P/E Ratio: 26.12

NAGE Technical Analysis vs Fundamental Analysis

Buy
53
Niagen Bioscience, Inc. (NAGE) is a Buy

Is Niagen Bioscience, Inc. a Buy or a Sell?